{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:04Z","timestamp":1793158144929,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02325-z","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:41:40Z","timestamp":1783392100000},"page":"5405-5422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuroinflammation in neurodegenerative diseases: pathogenic pathways and emerging pharmacotherapeutic targets in Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Ravi Ranjan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kamaljeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-0069","authenticated-orcid":false,"given":"Sourabh","family":"Kosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2325_CR1","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s disease facts and figures (2025) Alzheimer\u2019s & Dementia, 21(4), e70235. https:\/\/doi.org\/10.1002\/ALZ.70235","DOI":"10.1002\/ALZ.70235"},{"key":"2325_CR2","unstructured":"AD\/PD (2025) International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases and Related Neurological Disorders (no date). https:\/\/www.utmb.edu\/mitchellcenter\/home\/2025\/04\/01\/default-calendar\/ad-pd-2025--international-conference-on-alzheimer-s-and-parkinson-s-diseases-and-related-neurological-disorders. Accessed 5 Aug 2025"},{"key":"2325_CR3","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/FNAGI.2024.1347987\/XML","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A et al (2024a) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987. https:\/\/doi.org\/10.3389\/FNAGI.2024.1347987\/XML","journal-title":"Front Aging Neurosci"},{"key":"2325_CR4","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A et al (2024b) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987","journal-title":"Front Aging Neurosci"},{"key":"2325_CR5","doi-asserted-by":"publisher","first-page":"254248232513291","DOI":"10.1177\/25424823251329188","volume":"9","author":"LGMP Afrakoti","year":"2025","unstructured":"Afrakoti LGMP, Moghadam SD, Hadinezhad P (2025) Alzheimer\u2019s disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy. J Alzheimer\u2019s Disease Rep 9:25424823251329188. https:\/\/doi.org\/10.1177\/25424823251329188","journal-title":"J Alzheimer\u2019s Disease Rep"},{"issue":"7","key":"2325_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/CELLS13070581","volume":"13","author":"T Ageeva","year":"2024","unstructured":"Ageeva T, Rizvanov A, Mukhamedshina Y (2024) NF-\u03baB and JAK\/STAT signaling pathways as crucial regulators of neuroinflammation and astrocyte modulation in spinal cord injury. Cells 13(7):581. https:\/\/doi.org\/10.3390\/CELLS13070581","journal-title":"Cells"},{"issue":"1","key":"2325_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/S00415-024-12770-X","volume":"272","author":"M Alfaidi","year":"2024","unstructured":"Alfaidi M, Barker RA, Kuan WL (2024) An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease. J Neurol 272(1):21. https:\/\/doi.org\/10.1007\/S00415-024-12770-X","journal-title":"J Neurol"},{"key":"2325_CR8","unstructured":"Alzheimer\u2019s Genetic Risk Factors Spark Inflammation in Females | Newsroom | Weill Cornell Medicine (no date). https:\/\/news.weill.cornell.edu\/news\/2024\/09\/alzheimer%E2%80%99s-genetic-risk-factors-spark-inflammation-in-females. Accessed 3 Aug 2025"},{"issue":"7","key":"2325_CR10","doi-asserted-by":"publisher","first-page":"e14856","DOI":"10.1111\/CNS.14856","volume":"30","author":"M AmeliMojarad","year":"2024","unstructured":"AmeliMojarad M, AmeliMojarad M (2024) The neuroinflammatory role of microglia in Alzheimer\u2019s disease and their associated therapeutic targets. CNS Neurosci Ther 30(7):e14856. https:\/\/doi.org\/10.1111\/CNS.14856","journal-title":"CNS Neurosci Ther"},{"key":"2325_CR9","doi-asserted-by":"publisher","first-page":"1391517","DOI":"10.3389\/FNAGI.2024.1391517\/XML","volume":"16","author":"M Amelimojarad","year":"2024","unstructured":"Amelimojarad M, Amelimojarad M, Cui X (2024) The emerging role of brain neuroinflammatory responses in Alzheimer\u2019s disease. Front Aging Neurosci 16:1391517. https:\/\/doi.org\/10.3389\/FNAGI.2024.1391517\/XML","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2325_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/CELLS13060485","volume":"13","author":"S Anilkumar","year":"2024","unstructured":"Anilkumar S, Wright-Jin E (2024) NF-\u03baB as an inducible regulator of inflammation in the central nervous system. Cells 13(6):485. https:\/\/doi.org\/10.3390\/CELLS13060485","journal-title":"Cells"},{"issue":"1","key":"2325_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44400-025-00011-5","volume":"1","author":"A Auger","year":"2025","unstructured":"Auger A et al (2025) Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. npj Dement 1(1):1\u201318. https:\/\/doi.org\/10.1038\/s44400-025-00011-5","journal-title":"npj Dement"},{"key":"2325_CR14","doi-asserted-by":"publisher","first-page":"1434512","DOI":"10.3389\/FPHAR.2024.1434512\/BIBTEX","volume":"15","author":"AM Badawoud","year":"2024","unstructured":"Badawoud AM et al (2024) The relation between Parkinson\u2019s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis. Front Pharmacol 15:1434512. https:\/\/doi.org\/10.3389\/FPHAR.2024.1434512\/BIBTEX","journal-title":"Front Pharmacol"},{"issue":"1","key":"2325_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-024-03024-8","volume":"21","author":"W Balestri","year":"2024","unstructured":"Balestri W et al (2024) Modeling the neuroimmune system in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neuroinflammation 21(1):1\u201324. https:\/\/doi.org\/10.1186\/S12974-024-03024-8","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2325_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/NEUROLINT16030037","volume":"16","author":"E Bej","year":"2024","unstructured":"Bej E et al (2024) Oxidative stress and neurodegeneration: insights and therapeutic strategies for Parkinson\u2019s disease. Neurol Int 16(3):502. https:\/\/doi.org\/10.3390\/NEUROLINT16030037","journal-title":"Neurol Int"},{"issue":"1","key":"2325_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/S13024-025-00843-Y","volume":"20","author":"AA Belaidi","year":"2025","unstructured":"Belaidi AA, Bush AI, Ayton S (2025) Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Mol Neurodegeneration 20(1):47. https:\/\/doi.org\/10.1186\/S13024-025-00843-Y","journal-title":"Mol Neurodegeneration"},{"key":"2325_CR18","doi-asserted-by":"publisher","first-page":"106794","DOI":"10.1016\/j.nbd.2025.106794","volume":"207","author":"ML Bolen","year":"2025","unstructured":"Bolen ML et al (2025) Peripheral blood immune cells from individuals with Parkinson\u2019s disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs. Neurobiol Dis 207:106794. https:\/\/doi.org\/10.1016\/j.nbd.2025.106794","journal-title":"Neurobiol Dis"},{"key":"2325_CR19","doi-asserted-by":"publisher","first-page":"1439125","DOI":"10.3389\/FNEUR.2024.1439125","volume":"15","author":"Y Cantero-Fortiz","year":"2024","unstructured":"Cantero-Fortiz Y, Boada M (2024) The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer\u2019s, and Parkinson\u2019s disease\u2019. Front Neurol 15:1439125. https:\/\/doi.org\/10.3389\/FNEUR.2024.1439125","journal-title":"Front Neurol"},{"key":"2325_CR20","doi-asserted-by":"publisher","first-page":"103991","DOI":"10.1016\/J.MCN.2025.103991","volume":"132","author":"CC Castro","year":"2025","unstructured":"Castro CC et al (2025) Sex-specific cognitive benefits and anti-inflammatory effects of coumestrol pretreatment in transient global cerebral ischemia. Mol Cell Neurosci 132:103991. https:\/\/doi.org\/10.1016\/J.MCN.2025.103991","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"2325_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/S12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflamm 20(1):165. https:\/\/doi.org\/10.1186\/S12974-023-02853-3","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2325_CR21","doi-asserted-by":"publisher","first-page":"e00427","DOI":"10.1016\/J.NEUROT.2024.E00427","volume":"21","author":"KS Chen","year":"2024","unstructured":"Chen KS et al (2024) Stem cell therapeutics and gene therapy for neurologic disorders. Neurotherapeutics 21(4):e00427. https:\/\/doi.org\/10.1016\/J.NEUROT.2024.E00427","journal-title":"Neurotherapeutics"},{"issue":"14","key":"2325_CR23","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/IJMS25147952","volume":"25","author":"EH Choi","year":"2024","unstructured":"Choi EH, Kim MH, Park SJ (2024) Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment. Int J Mol Sci 25(14):7952. https:\/\/doi.org\/10.3390\/IJMS25147952","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2325_CR24","doi-asserted-by":"publisher","first-page":"e10367","DOI":"10.1002\/BTM2.10367","volume":"8","author":"P Chopade","year":"2022","unstructured":"Chopade P et al (2022) Alzheimer\u2019s and Parkinson\u2019s disease therapies in the clinic. Bioeng Transl Med 8(1):e10367. https:\/\/doi.org\/10.1002\/BTM2.10367","journal-title":"Bioeng Translational Med"},{"issue":"Suppl1","key":"2325_CR25","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.4103\/0976-500X.120975","volume":"4","author":"M Ciriaco","year":"2013","unstructured":"Ciriaco M et al (2013) Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacotherapeutics 4(Suppl1):S94. https:\/\/doi.org\/10.4103\/0976-500X.120975","journal-title":"J Pharmacol Pharmacotherapeutics"},{"issue":"6","key":"2325_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/S00702-025-02902-6\/TABLES\/5","volume":"132","author":"SEV Cook","year":"2025","unstructured":"Cook SEV et al (2025) Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study. J Neural Transm 132(6):811\u2013826. https:\/\/doi.org\/10.1007\/S00702-025-02902-6\/TABLES\/5","journal-title":"J Neural Transm"},{"issue":"2","key":"2325_CR27","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.1002\/TRC2.12465","volume":"10","author":"J Cummings","year":"2024","unstructured":"Cummings J et al (2024) Alzheimer\u2019s disease drug development pipeline: 2024. Alzheimer\u2019s Dementia: Translational Res Clin Interventions 10(2):e12465. https:\/\/doi.org\/10.1002\/TRC2.12465","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"2325_CR28","doi-asserted-by":"publisher","unstructured":"Cummings JL et al (2025) Alzheimer\u2019s disease drug development pipeline: 2025, Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions, 11(2), e70098. https:\/\/doi.org\/10.1002\/TRC2.70098","DOI":"10.1002\/TRC2.70098"},{"key":"2325_CR29","doi-asserted-by":"publisher","unstructured":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (Review) (no date). https:\/\/doi.org\/10.3892\/ijmm.2018.3406. Accessed 4 Aug 2025","DOI":"10.3892\/ijmm.2018.3406"},{"key":"2325_CR30","doi-asserted-by":"publisher","first-page":"1231706","DOI":"10.3389\/FRAGI.2023.1231706","volume":"4","author":"SF Darwish","year":"2023","unstructured":"Darwish SF et al (2023) The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases. Front Aging 4:1231706. https:\/\/doi.org\/10.3389\/FRAGI.2023.1231706","journal-title":"Front Aging"},{"issue":"Suppl 1","key":"2325_CR31","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.5152\/EURASIANJMED.2023.23349","volume":"55","author":"N Demirtas","year":"2023","unstructured":"Demirtas N, Sahin-Mazlumoglu B, Palabiyik-Yucelik SS (2023) Role of NLRP3 Inflammasomes in Neurodegenerative Diseases. Eurasian J Med 55(Suppl 1):S98. https:\/\/doi.org\/10.5152\/EURASIANJMED.2023.23349","journal-title":"Eurasian J Med"},{"key":"2325_CR32","doi-asserted-by":"publisher","first-page":"1569717","DOI":"10.3389\/FMMED.2025.1569717","volume":"5","author":"TB Derso","year":"2025","unstructured":"Derso TB et al (2025) Neural stem cells in adult neurogenesis and their therapeutic applications in neurodegenerative disorders: a concise review. Front Mol Med 5:1569717. https:\/\/doi.org\/10.3389\/FMMED.2025.1569717","journal-title":"Front Mol Med"},{"issue":"4","key":"2325_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/CELLS14040243","volume":"14","author":"D Dias","year":"2025","unstructured":"Dias D et al (2025) From genetics to neuroinflammation: the impact of ApoE4 on microglial function in Alzheimer\u2019s disease. Cells 14(4):243. https:\/\/doi.org\/10.3390\/CELLS14040243","journal-title":"Cells"},{"issue":"9","key":"2325_CR35","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.4103\/1673-5374.306064","volume":"16","author":"Z Ding","year":"2021","unstructured":"Ding Z, Bin et al (2021) Astrocytes: a double-edged sword in neurodegenerative diseases. Neural Regeneration Res 16(9):1702. https:\/\/doi.org\/10.4103\/1673-5374.306064","journal-title":"Neural Regeneration Res"},{"key":"2325_CR36","doi-asserted-by":"publisher","first-page":"1579511","DOI":"10.3389\/FNINS.2025.1579511","volume":"19","author":"J Doroszkiewicz","year":"2025","unstructured":"Doroszkiewicz J, Winkel I, Mroczko B (2025) Comparative analysis of neuroinflammatory pathways in Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis: insights into similarities and distinctions. Front NeuroSci 19:1579511. https:\/\/doi.org\/10.3389\/FNINS.2025.1579511","journal-title":"Front NeuroSci"},{"issue":"3","key":"2325_CR90","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/J.NEUMAR.2025.100111","volume":"2","author":"JCC dos Santos","year":"2025","unstructured":"dos Santos JCC (2025) Role of gut-microbiome-brain axis in neurodegenerative diseases: A narrative review of mechanisms, therapeutics, and emerging perspectives. NeuroMarkers 2(3):100111. https:\/\/doi.org\/10.1016\/J.NEUMAR.2025.100111","journal-title":"NeuroMarkers"},{"issue":"1","key":"2325_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-025-00828-X","volume":"20","author":"MR Duggan","year":"2025","unstructured":"Duggan MR et al (2025) Immune modulation to treat Alzheimer\u2019s disease. Mol Neurodegeneration 20(1):1\u201317. https:\/\/doi.org\/10.1186\/S13024-025-00828-X","journal-title":"Mol Neurodegeneration"},{"issue":"23","key":"2325_CR38","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.3390\/JCM13237243","volume":"13","author":"H Eo","year":"2024","unstructured":"Eo H et al (2024) Alpha-synuclein and microglia in Parkinson\u2019s disease: from pathogenesis to therapeutic prospects. J Clin Med 13(23):7243. https:\/\/doi.org\/10.3390\/JCM13237243","journal-title":"J Clin Med"},{"key":"2325_CR39","unstructured":"Evolving neurology and neuroinflammation therapies and trials in 2025 (no date). https:\/\/www.clinicalleader.com\/doc\/evolving-neurology-and-neuroinflammation-therapies-and-trials-in-0001. Accessed 5 Aug 2025"},{"key":"2325_CR40","doi-asserted-by":"publisher","first-page":"254248232513418","DOI":"10.1177\/25424823251341870","volume":"9","author":"S Fakorede","year":"2025","unstructured":"Fakorede S et al (2025) Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease Rep 9:25424823251341870. https:\/\/doi.org\/10.1177\/25424823251341870","journal-title":"J Alzheimer\u2019s Disease Rep"},{"key":"2325_CR41","doi-asserted-by":"publisher","first-page":"105080","DOI":"10.1016\/J.NEUINT.2021.105080","volume":"148","author":"YY Fan","year":"2021","unstructured":"Fan YY, Huo J (2021) A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils? Neurochem Int 148:105080. https:\/\/doi.org\/10.1016\/J.NEUINT.2021.105080","journal-title":"Neurochem Int"},{"key":"2325_CR42","doi-asserted-by":"publisher","first-page":"855776","DOI":"10.3389\/FNAGI.2022.855776\/XML","volume":"14","author":"M Fathi","year":"2022","unstructured":"Fathi M et al (2022) Pre-clinical studies identifying molecular pathways of neuroinflammation in Parkinson\u2019s disease: a systematic review. Front Aging Neurosci 14:855776. https:\/\/doi.org\/10.3389\/FNAGI.2022.855776\/XML","journal-title":"Front Aging Neurosci"},{"key":"2325_CR43","doi-asserted-by":"publisher","unstructured":"Feng Y et al (2019) Triptolide inhibits preformed fibril-induced microglial activation by targeting the MicroRNA155-5p\/SHIP1 pathway. Oxidative Medicine and Cellular Longevity, 6527638. https:\/\/doi.org\/10.1155\/2019\/6527638","DOI":"10.1155\/2019\/6527638"},{"issue":"6","key":"2325_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/S11306-024-02181-4","volume":"20","author":"X Flores-Ponce","year":"2024","unstructured":"Flores-Ponce X, Velasco I (2024) Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease. Metabolomics 20(6):116. https:\/\/doi.org\/10.1007\/S11306-024-02181-4","journal-title":"Metabolomics"},{"key":"2325_CR45","doi-asserted-by":"publisher","unstructured":"Gao C et al (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduction and Targeted Therapy 2023 8:1, 8(1), 1\u201337. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","DOI":"10.1038\/s41392-023-01588-0"},{"issue":"1","key":"2325_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.14336\/AD.2024.1629","volume":"17","author":"R Gao","year":"2025","unstructured":"Gao R et al (2025) Decoding microglial polarization and metabolic reprogramming in neurodegenerative diseases: implications for disease progression and therapy. Aging Dis 17(1):91. https:\/\/doi.org\/10.14336\/AD.2024.1629","journal-title":"Aging Disease"},{"issue":"6","key":"2325_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/CIMB47060417","volume":"47","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez M (2025) Neuroinflammation: mechanisms, dual roles, and therapeutic strategies in neurological disorders. Curr Issues Mol Biol 47(6):417. https:\/\/doi.org\/10.3390\/CIMB47060417","journal-title":"Curr Issues Mol Biol"},{"key":"2325_CR48","doi-asserted-by":"publisher","first-page":"815347","DOI":"10.3389\/FNAGI.2022.815347\/FULL","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y (2022) Microglia Polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci 14:815347. https:\/\/doi.org\/10.3389\/FNAGI.2022.815347\/FULL","journal-title":"Front Aging Neurosci"},{"key":"2325_CR49","doi-asserted-by":"publisher","first-page":"1554398","DOI":"10.3389\/FNAGI.2025.1554398\/XML","volume":"17","author":"C He","year":"2025","unstructured":"He C et al (2025) The dual role of microglia in Alzheimer\u2019s disease: from immune regulation to pathological progression. Front Aging Neurosci 17:1554398. https:\/\/doi.org\/10.3389\/FNAGI.2025.1554398\/XML","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2325_CR50","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT et al (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry 2025 30(6):2783\u20132798. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","journal-title":"Mol Psychiatry 2025"},{"key":"2325_CR51","doi-asserted-by":"publisher","unstructured":"Hong H et al (2024) Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson\u2019s disease. J Neuroinflamm 21(1). https:\/\/doi.org\/10.1186\/S12974-024-03210-8","DOI":"10.1186\/S12974-024-03210-8"},{"key":"2325_CR52","doi-asserted-by":"publisher","unstructured":"Houldsworth A (2023) Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants. Brain Commun 6(1). https:\/\/doi.org\/10.1093\/BRAINCOMMS\/FCAD356","DOI":"10.1093\/BRAINCOMMS\/FCAD356"},{"issue":"JUL","key":"2325_CR53","doi-asserted-by":"publisher","first-page":"403086","DOI":"10.3389\/FPHAR.2018.00790\/XML","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua S et al (2018) Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front Pharmacol 9(JUL):403086. https:\/\/doi.org\/10.3389\/FPHAR.2018.00790\/XML","journal-title":"Front Pharmacol"},{"key":"2325_CR54","doi-asserted-by":"publisher","unstructured":"Hulse J, Bhaskar K (2022) Crosstalk between the NLRP3 inflammasome\/ASC speck and amyloid protein aggregates drives disease progression in Alzheimer\u2019s and Parkinson\u2019s disease. Front Mol Neurosci 15. https:\/\/doi.org\/10.3389\/FNMOL.2022.805169","DOI":"10.3389\/FNMOL.2022.805169"},{"key":"2325_CR55","doi-asserted-by":"crossref","unstructured":"Jain M et al (2021) Role of JAK\/STAT in the Neuroinflammation and its association with neurological disorders. Annals Neurosci 28(3\u20134):191\u2013200. http:\/\/doi.org\/10.1177\/09727531211070532\/ASSET\/A916786B-11AF-4AF0-8178-A0D46208805B\/ASSETS\/IMAGES\/LARGE\/10.1177_09727531211070532-FIG2.JPG","DOI":"10.1177\/09727531211070532"},{"issue":"1","key":"2325_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-024-00849-1","volume":"11","author":"P Kallunki","year":"2025","unstructured":"Kallunki P et al (2025) Rational selection of the monoclonal \u03b1-synuclein antibody amlenetug (Lu AF82422) for the treatment of \u03b1-synucleinopathies. npj Parkinson\u2019s Disease 11(1):1\u201319. https:\/\/doi.org\/10.1038\/S41531-024-00849-1;SUBJMETA=153,2778,308,692;KWRD=DRUG+DEVELOPMENT,PRECLINICAL+RESEARCH","journal-title":"npj Parkinson\u2019s Disease"},{"key":"2325_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/J.IBNEUR.2025.05.005","volume":"18","author":"P Kamila","year":"2025","unstructured":"Kamila P et al (2025) Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments. IBRO Neurosci Rep 18:771\u2013782. https:\/\/doi.org\/10.1016\/J.IBNEUR.2025.05.005","journal-title":"IBRO Neurosci Rep"},{"key":"2325_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/J.CELLIMM.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN et al (2018) Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https:\/\/doi.org\/10.1016\/J.CELLIMM.2018.02.011","journal-title":"Cell Immunol"},{"key":"2325_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1602495","author":"P Khanal","year":"2025","unstructured":"Khanal P, Chikhale R, Machhi J (2025) Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseases. Front Pharmacol. 16https:\/\/doi.org\/10.3389\/fphar.2025.1602495","journal-title":"Front Pharmacol"},{"issue":"1","key":"2325_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/09727531221136349","volume":"30","author":"S Kharel","year":"2022","unstructured":"Kharel S, Ojha R (2022) Future of monoclonal antibody therapy in Parkinson\u2019s disease. Annals Neurosci 30(1):8. https:\/\/doi.org\/10.1177\/09727531221136349","journal-title":"Annals Neurosciences"},{"issue":"1","key":"2325_CR63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/CIMB47010008","volume":"47","author":"ME Kim","year":"2024","unstructured":"Kim ME, Lee JS (2024) Mechanisms and emerging regulators of neuroinflammation: exploring new therapeutic strategies for neurological disorders. Curr Issues Mol Biol 47(1):8. https:\/\/doi.org\/10.3390\/CIMB47010008","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"2325_CR64","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/S12276-022-00895-W","volume":"54","author":"TK Kim","year":"2022","unstructured":"Kim TK et al (2022) Inflammation promotes synucleinopathy propagation. Exp Mol Med 54(12):2148. https:\/\/doi.org\/10.1038\/S12276-022-00895-W","journal-title":"Exp Mol Med"},{"key":"2325_CR62","doi-asserted-by":"publisher","unstructured":"Kim BH et al (2025) Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Translational Neurodegeneration 14(1). https:\/\/doi.org\/10.1186\/S40035-025-00465-W","DOI":"10.1186\/S40035-025-00465-W"},{"issue":"12","key":"2325_CR65","doi-asserted-by":"publisher","first-page":"e0307577","DOI":"10.1371\/JOURNAL.PONE.0307577","volume":"19","author":"AS Latham","year":"2024","unstructured":"Latham AS et al (2024) Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain. PLoS ONE 19(12):e0307577. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0307577","journal-title":"PLoS ONE"},{"key":"2325_CR66","doi-asserted-by":"publisher","first-page":"1478741","DOI":"10.3389\/FNCEL.2024.1478741\/XML","volume":"18","author":"H Li","year":"2024","unstructured":"Li H et al (2024) Targeting astrocytes polarization after spinal cord injury: a promising direction. Front Cell Neurosci 18:1478741. https:\/\/doi.org\/10.3389\/FNCEL.2024.1478741\/XML","journal-title":"Front Cell Neurosci"},{"key":"2325_CR68","doi-asserted-by":"publisher","unstructured":"Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 23(8). https:\/\/doi.org\/10.3390\/IJMS23084148","DOI":"10.3390\/IJMS23084148"},{"issue":"3","key":"2325_CR67","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.14336\/AD.2024.0373","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H et al (2025) The role of the complement system in synaptic pruning after stroke. Aging Dis 16(3):1452\u20131470. https:\/\/doi.org\/10.14336\/AD.2024.0373","journal-title":"Aging Disease"},{"issue":"6","key":"2325_CR69","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/14737175.2025.2500752","volume":"25","author":"M Lozupone","year":"2025","unstructured":"Lozupone M et al (2025) Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: the challenges ahead. Expert Rev Neurother 25(6):649\u2013659. https:\/\/doi.org\/10.1080\/14737175.2025.2500752","journal-title":"Expert Rev Neurother"},{"key":"2325_CR70","doi-asserted-by":"publisher","first-page":"1498756","DOI":"10.3389\/FNAGI.2024.1498756\/BIBTEX","volume":"16","author":"Y Luo","year":"2024","unstructured":"Luo Y et al (2024) Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front Aging Neurosci 16:1498756. https:\/\/doi.org\/10.3389\/FNAGI.2024.1498756\/BIBTEX","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"2325_CR71","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.1002\/ALZ.14298;JOURNAL:JOURNAL:15525279","volume":"20","author":"LS Madsen","year":"2024","unstructured":"Madsen LS et al (2024) Microglial responses partially mediate the effect of A\u03b2 on cognition in Alzheimer\u2019s disease. Alzheimer\u2019s Dement 20(11):8028\u20138037. https:\/\/doi.org\/10.1002\/ALZ.14298;JOURNAL:JOURNAL:15525279","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"2325_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/PH18010104","volume":"18","author":"R Mallick","year":"2025","unstructured":"Mallick R et al (2025) Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies. Pharmaceuticals 18(1):104. https:\/\/doi.org\/10.3390\/PH18010104","journal-title":"Pharmaceuticals"},{"issue":"7","key":"2325_CR74","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4103\/1673-5374.387991","volume":"19","author":"JJ Maran","year":"2024","unstructured":"Maran JJ, Mugisho OO (2024) NLRP3 inflammasome plays a vital role in the pathogenesis of age-related diseases in the eye and brain. Neural Regeneration Res 19(7):1425\u20131426. https:\/\/doi.org\/10.4103\/1673-5374.387991","journal-title":"Neural Regeneration Res"},{"key":"2325_CR75","doi-asserted-by":"crossref","unstructured":"McCrea LT et al (2025) Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of synaptic pruning. Neuropsychopharmacology 50(10):1544\u20131552","DOI":"10.1038\/s41386-025-02123-1"},{"issue":"5","key":"2325_CR76","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JPD-240272","volume":"14","author":"K McFarthing","year":"2024","unstructured":"McFarthing K et al (2024) Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2024 Update. J Parkinson\u2019s Dis 14(5):899. https:\/\/doi.org\/10.3233\/JPD-240272","journal-title":"J Parkinson\u2019s Disease"},{"issue":"4","key":"2325_CR77","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4103\/BC.BC_38_24","volume":"10","author":"R Mi","year":"2024","unstructured":"Mi R et al (2024) Effects and mechanisms of long-acting glucagon-like peptide-1 receptor agonist semaglutide on microglia phenotypic transformation and neuroinflammation after cerebral ischemia\/reperfusion in rats. Brain Circulation 10(4):354\u2013365. https:\/\/doi.org\/10.4103\/BC.BC_38_24","journal-title":"Brain Circulation"},{"key":"2325_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2025.1575022\/PDF","author":"L M\u00fcller","year":"2025","unstructured":"M\u00fcller L, Di Benedetto S (2025) Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation. Front Cell Neurosci. 19https:\/\/doi.org\/10.3389\/FNCEL.2025.1575022\/PDF","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2325_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12950-023-00328-Z\/FIGURES\/14","volume":"20","author":"S Myers","year":"2023","unstructured":"Myers S et al (2023) Anti-inflammatory effects of \u03b2-FNA are sex-dependent in a pre-clinical model of LPS-induced inflammation. J Inflamm (United Kingdom) 20(1):1\u201325. https:\/\/doi.org\/10.1186\/S12950-023-00328-Z\/FIGURES\/14","journal-title":"J Inflamm (United Kingdom)"},{"key":"2325_CR80","doi-asserted-by":"publisher","first-page":"1396520","DOI":"10.3389\/FNEUR.2024.1396520\/XML","volume":"15","author":"L Negro-Demontel","year":"2024","unstructured":"Negro-Demontel L et al (2024) The complement system in neurodegenerative and inflammatory diseases of the central nervous system. Front Neurol 15:1396520. https:\/\/doi.org\/10.3389\/FNEUR.2024.1396520\/XML","journal-title":"Front Neurol"},{"key":"2325_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.ADDR.2019.05.003","volume":"148","author":"CL Nemeth","year":"2019","unstructured":"Nemeth CL, Fine AS, Fatemi A (2019) Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology. Adv Drug Deliv Rev 148:60\u201367. https:\/\/doi.org\/10.1016\/J.ADDR.2019.05.003","journal-title":"Adv Drug Deliv Rev"},{"key":"2325_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/J.MOLIMM.2025.07.014","volume":"185","author":"D-A Nie","year":"2025","unstructured":"Nie D-A et al (2025) The role of microglia in neurodegenerative diseases. Mol Immunol 185:127\u2013135. https:\/\/doi.org\/10.1016\/J.MOLIMM.2025.07.014","journal-title":"Mol Immunol"},{"issue":"6","key":"2325_CR83","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/S00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT (2025) The gut\u2013brain axis in early Parkinson\u2019s disease: from prodrome to prevention. J Neurol 272(6):413. https:\/\/doi.org\/10.1007\/S00415-025-13138-5","journal-title":"J Neurol"},{"key":"2325_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JOCN.2017.05.040","volume":"44","author":"D Parissis","year":"2017","unstructured":"Parissis D, Syntila SA, Ioannidis P (2017) Corticosteroids in neurological disorders: The dark side. J Clin Neurosci 44:1\u20135. https:\/\/doi.org\/10.1016\/J.JOCN.2017.05.040","journal-title":"J Clin Neurosci"},{"key":"2325_CR85","doi-asserted-by":"publisher","unstructured":"Pizcueta P et al (2023) Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: leriglitazone as a promising candidate. Int J Mol Sci 24(4). https:\/\/doi.org\/10.3390\/IJMS24043201","DOI":"10.3390\/IJMS24043201"},{"issue":"45","key":"2325_CR86","doi-asserted-by":"publisher","first-page":"33247","DOI":"10.1039\/D4RA06330A","volume":"14","author":"D Priya","year":"2024","unstructured":"Priya D et al (2024) Novel PPAR-\u03b3 agonists as potential neuroprotective agents against Alzheimer\u2019s disease: rational design, synthesis, in silico evaluation, PPAR-\u03b3 binding assay and transactivation and expression studies. RSC Adv 14(45):33247\u201333266. https:\/\/doi.org\/10.1039\/D4RA06330A","journal-title":"RSC Adv"},{"key":"2325_CR87","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/J.CRPHAR.2022.100149","volume":"4","author":"V Rani","year":"2023","unstructured":"Rani V et al (2023) Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds. Curr Res Pharmacol Drug Discovery 4:100149. https:\/\/doi.org\/10.1016\/J.CRPHAR.2022.100149","journal-title":"Curr Res Pharmacol Drug Discovery"},{"issue":"3","key":"2325_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21767\/JCNB-24.3.26","volume":"4","author":"E Rose","year":"2024","unstructured":"Rose E (2024) Neuroinflammation as a therapeutic target in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Neurobiol 4(3):30\u201330. https:\/\/doi.org\/10.21767\/JCNB-24.3.26","journal-title":"Curr Neurobiol"},{"issue":"22","key":"2325_CR89","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3390\/IJMS252211941","volume":"25","author":"F Roveta","year":"2024","unstructured":"Roveta F et al (2024) Neuroinflammatory biomarkers in Alzheimer\u2019s disease: from pathophysiology to clinical implications. Int J Mol Sci 25(22):11941. https:\/\/doi.org\/10.3390\/IJMS252211941","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2325_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2478\/amma-2025-0018","volume":"71","author":"A Sharma","year":"2025","unstructured":"Sharma A et al (2025) The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases. Acta Marisiensis-Seria Med 71(2):95\u2013105. https:\/\/doi.org\/10.2478\/amma-2025-0018","journal-title":"Acta Marisiensis-Seria Med"},{"key":"2325_CR92","doi-asserted-by":"publisher","unstructured":"Shi F-D, Yong VW (2025) Neuroinflammation across neurological diseases. Science 388(6753). https:\/\/doi.org\/10.1126\/SCIENCE.ADX0043\/ASSET\/DE5CBE22-9FF2-4835-8718-0B9311FBB2E7\/ASSETS\/IMAGES\/LARGE\/SCIENCE.ADX0043-FA.JPG","DOI":"10.1126\/SCIENCE.ADX0043\/ASSET\/DE5CBE22-9FF2-4835-8718-0B9311FBB2E7\/ASSETS\/IMAGES\/LARGE\/SCIENCE.ADX0043-FA.JPG"},{"issue":"2","key":"2325_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.36922\/IMO025050007","volume":"2","author":"AS Singh","year":"2025","unstructured":"Singh AS, Naqvi AR, Chanu MT (2025) Neuroinflammation and progress in clinical trials for the treatment of Alzheimer\u2019s disease and related dementias: an update. Innovative Med Omics 2(2):36\u201350. https:\/\/doi.org\/10.36922\/IMO025050007","journal-title":"Innovative Med Omics"},{"issue":"1","key":"2325_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.BRAINRESBULL.2011.10.004","volume":"87","author":"JA Smith","year":"2011","unstructured":"Smith JA et al (2011) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87(1):10. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2011.10.004","journal-title":"Brain Res Bull"},{"issue":"7","key":"2325_CR95","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.4103\/NRR.NRR-D-24-00284","volume":"20","author":"R Socodato","year":"2025","unstructured":"Socodato R, Relvas JB (2025) Neuroinflammation revisited through the microglial lens. Neural Regeneration Res 20(7):1989\u20131990. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00284","journal-title":"Neural Regeneration Res"},{"key":"2325_CR96","doi-asserted-by":"publisher","unstructured":"Su D et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388. https:\/\/doi.org\/10.1136\/BMJ-2024-080952","DOI":"10.1136\/BMJ-2024-080952"},{"issue":"1","key":"2325_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-024-00640-2","volume":"10","author":"T Thi Lai","year":"2024","unstructured":"Thi Lai T et al (2024) Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson\u2019s disease mouse model. npj Parkinson\u2019s Disease 10(1):1\u201310. https:\/\/doi.org\/10.1038\/S41531-024-00640-2;SUBJMETA=1689,1718,364,375,378,631,692,699;KWRD=NEURODEGENERATION,PARKINSON","journal-title":"npj Parkinson\u2019s Disease"},{"key":"2325_CR98","doi-asserted-by":"publisher","first-page":"1506358","DOI":"10.3389\/FNINS.2024.1506358\/XML","volume":"18","author":"AR Trainor","year":"2024","unstructured":"Trainor AR, MacDonald DS, Penney J (2024) Microglia: roles and genetic risk in Parkinson\u2019s disease. Front NeuroSci 18:1506358. https:\/\/doi.org\/10.3389\/FNINS.2024.1506358\/XML","journal-title":"Front NeuroSci"},{"key":"2325_CR99","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/DNND.S452009","volume":"14","author":"PN Tripathi","year":"2024","unstructured":"Tripathi PN et al (2024) Review of Pharmacotherapeutic Targets in Alzheimer\u2019s Disease and Its Management Using Traditional Medicinal Plants. Degenerative Neurol Neuromuscul Disease 14:47. https:\/\/doi.org\/10.2147\/DNND.S452009","journal-title":"Degenerative Neurol Neuromuscul Disease"},{"key":"2325_CR100","doi-asserted-by":"publisher","unstructured":"Vadukul DM et al (2023) \u03b1-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-\u03b2 42 via Heterogeneous Primary Nucleation. J Am Chem Soc 145(33):18276\u201318285. https:\/\/doi.org\/10.1021\/JACS.3C03212.","DOI":"10.1021\/JACS.3C03212"},{"issue":"1","key":"2325_CR101","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/J.TJPAD.2024.100013","volume":"12","author":"Z Valiukas","year":"2025","unstructured":"Valiukas Z et al (2025) Microglial activation states and their implications for Alzheimer\u2019s Disease. J Prev Alzheimer\u2019s Disease 12(1):100013. https:\/\/doi.org\/10.1016\/J.TJPAD.2024.100013","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"2325_CR102","doi-asserted-by":"publisher","first-page":"116884","DOI":"10.1016\/J.BIOPHA.2024.116884","volume":"177","author":"CP Vieira","year":"2024","unstructured":"Vieira CP et al (2024) Estimating the therapeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation. Biomed Pharmacother 177:116884. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.116884","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"2325_CR103","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.WNL.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad SC et al (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70(19):1672\u20131677. https:\/\/doi.org\/10.1212\/01.WNL.0000311269.57716.63","journal-title":"Neurology"},{"issue":"4","key":"2325_CR104","doi-asserted-by":"publisher","first-page":"105685","DOI":"10.1016\/J.JBSPIN.2023.105685","volume":"91","author":"T Wirth","year":"2024","unstructured":"Wirth T, Lafforgue P, Pham T (2024) NSAID: Current limits to prescription. Joint Bone Spine 91(4):105685. https:\/\/doi.org\/10.1016\/J.JBSPIN.2023.105685","journal-title":"Joint Bone Spine"},{"key":"2325_CR105","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/J.NEUINT.2024.105880","volume":"180","author":"J Wu","year":"2024","unstructured":"Wu J et al (2024) Protein aggregation and its affecting mechanisms in neurodegenerative diseases. Neurochem Int 180:105880. https:\/\/doi.org\/10.1016\/J.NEUINT.2024.105880","journal-title":"Neurochem Int"},{"issue":"4","key":"2325_CR106","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R (2025) NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol 2025 22(4):341\u2013355. https:\/\/doi.org\/10.1038\/s41423-025-01275-w","journal-title":"Cell Mol Immunol 2025"},{"key":"2325_CR108","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/J.BIONPS.2023.100074","volume":"9","author":"KY Yamashita","year":"2023","unstructured":"Yamashita KY et al (2023) Biomarkers in Parkinson\u2019s disease: A state of the art review. Biomarkers Neuropsychiatry 9:100074. https:\/\/doi.org\/10.1016\/J.BIONPS.2023.100074","journal-title":"Biomarkers Neuropsychiatry"},{"key":"2325_CR109","doi-asserted-by":"publisher","unstructured":"Yan B et al (2024) A Review: The Significance of Toll-Like Receptors 2 and 4, and NF-\u03baB Signaling in Endothelial Cells during Atherosclerosis. Front Bioscience - Landmark 29(4). https:\/\/doi.org\/10.31083\/J.FBL2904161","DOI":"10.31083\/J.FBL2904161"},{"key":"2325_CR110","unstructured":"Yasir M, Goyal A, Sonthalia S (2023) Corticosteroid Adverse Effects. StatPearls [Preprint]. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531462\/ (Accessed: 5 August 2025)"},{"issue":"8","key":"2325_CR111","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.4103\/1673-5374.332128","volume":"17","author":"F Zahedipour","year":"2022","unstructured":"Zahedipour F et al (2022) Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases. Neural Regeneration Res 17(8):1675. https:\/\/doi.org\/10.4103\/1673-5374.332128","journal-title":"Neural Regeneration Res"},{"issue":"2","key":"2325_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0B013E318034194E","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, Inflammation and Pain. Int Anesthesiol Clin 45(2):27. https:\/\/doi.org\/10.1097\/AIA.0B013E318034194E","journal-title":"Int Anesthesiol Clin"},{"issue":"1","key":"2325_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy 8(1):1\u201332. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Therapy"},{"key":"2325_CR113","doi-asserted-by":"publisher","unstructured":"Zhang J et al (2024a) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Therapy 9(1):1\u201335. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","DOI":"10.1038\/s41392-024-01911-3"},{"key":"2325_CR114","doi-asserted-by":"publisher","unstructured":"Zhang Q et al (2024b) Neuroinflammation in Alzheimer\u2019s disease: insights from peripheral immune cells. Immun Ageing 21(1):1\u201325. https:\/\/doi.org\/10.1186\/S12979-024-00445-0","DOI":"10.1186\/S12979-024-00445-0"},{"issue":"1","key":"2325_CR115","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/S13024-025-00812-5","volume":"20","author":"S Zhang","year":"2025","unstructured":"Zhang S et al (2025) Peripheral and central neuroimmune mechanisms in Alzheimer\u2019s disease pathogenesis. Mol Neurodegeneration 20(1):22. https:\/\/doi.org\/10.1186\/S13024-025-00812-5","journal-title":"Mol Neurodegeneration"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02325-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:45:19Z","timestamp":1787924719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02325-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2325"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02325-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}